Distinct hepatic macrophage populations in lean and obese mice

Frontiers in Endocrinology

Volumn 7, Issue DEC, 2016, Pages

  Monibas, Rafael Mayoral ^a,b   Johnson, Andrew M F ^c   Osborn, Olivia ^c   Traves, Paqui G ^d   Mahata, Sushil K ^c,e  

^a MERCK RESEARCH LABORATORIES   (United States)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^d SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

^e VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

Author keywords

Hepatocytes; Immunometabolism; Inflammation; Insulin resistance; Kupffer cells; Obesity

Indexed keywords

ACUTE PHASE PROTEIN; GLIAL FIBRILLARY ACIDIC PROTEIN; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR;

DIET INDUCED OBESITY; ENDOTHELIUM CELL; GENE EXPRESSION; HEPATITIS; HUMAN; IMMUNITY; INSULIN RESISTANCE; KUPFFER CELL; LEAN BODY WEIGHT; LIPID METABOLISM; LIPID STORAGE; LIPOTOXICITY; LIVER CIRRHOSIS; LIVER FAILURE; LIVER FIBROSIS; METABOLIC STRESS; METABOLIC SYNDROME X; METABOLISM; NATURAL KILLER CELL; NONALCOHOLIC FATTY LIVER; NONHUMAN; OBESITY; SHORT SURVEY; STELLATE CELL;

EID: 85008214483     PISSN: None     EISSN: 16642392     Source Type: Journal    
DOI: 10.3389/fendo.2016.00152     Document Type: Short Survey

References (96)

1. Fotbolcu H, Zorlu E. Nonalcoholic fatty liver disease as a multi-systemic disease. World J Gastroenterol (2016) 22(16):4079-90. doi:10.3748/wjg.v22.i16.4079
2. Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science (1993) 259(5091):87-91. doi:10.1126/science.7678183
3. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW Jr. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest (2003) 112(12):1796-808. doi:10.1172/JCI200319246
4. Xu H, Barnes GT, Yang Q, Tan G, Yang D, Chou CJ, et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest (2003) 112(12):1821-30. doi:10.1172/JCI200319451
5. McNelis JC, Olefsky JM. Macrophages, immunity, and metabolic disease. Immunity (2014) 41(1):36-48. doi:10.1016/j.immuni.2014.05.010
6. Varma V, Yao-Borengasser A, Rasouli N, Nolen GT, Phanavanh B, Starks T, et al. Muscle inflammatory response and insulin resistance: synergistic interaction between macrophages and fatty acids leads to impaired insulin action. Am J Physiol Endocrinol Metab (2009) 296(6):E1300-10. doi:10.1152/ajpendo.90885.2008
7. Fink LN, Costford SR, Lee YS, Jensen TE, Bilan PJ, Oberbach A, et al. Pro-inflammatory macrophages increase in skeletal muscle of high fat-fed mice and correlate with metabolic risk markers in humans. Obesity (Silver Spring) (2014) 22(3):747-57. doi:10.1002/oby.20615
8. Patsouris D, Cao JJ, Vial G, Bravard A, Lefai E, Durand A, et al. Insulin resistance is associated with MCP1-mediated macrophage accumulation in skeletal muscle in mice and humans. PLoS One (2014) 9(10):e110653. doi:10.1371/journal.pone.0110653
9. Boon MR, Bakker LE, Haks MC, Quinten E, Schaart G, Van Beek L, et al. Short-term high-fat diet increases macrophage markers in skeletal muscle accompanied by impaired insulin signalling in healthy male subjects. Clin Sci (Lond) (2015) 128(2):143-51. doi:10.1042/CS20140179
10. Obstfeld AE, Sugaru E, Thearle M, Francisco AM, Gayet C, Ginsberg HN, et al. C-C chemokine receptor 2 (CCR2) regulates the hepatic recruitment of myeloid cells that promote obesity-induced hepatic steatosis. Diabetes (2010) 59(4):916-25. doi:10.2337/db09-1403
11. Bian Z, Peng Y, You Z, Wang Q, Miao Q, Liu Y, et al. CCN1 expression in hepatocytes contributes to macrophage infiltration in nonalcoholic fatty liver disease in mice. J Lipid Res (2013) 54(1):44-54. doi:10.1194/jlr.M026013
12. Morinaga H, Mayoral R, Heinrichsdorff J, Osborn O, Franck N, Hah N, et al. Characterization of distinct subpopulations of hepatic macrophages in HFD/obese mice. Diabetes (2015) 64(4):1120-30. doi:10.2337/db14-1238
13. Ehses JA, Perren A, Eppler E, Ribaux P, Pospisilik JA, Maor-Cahn R, et al. Increased number of islet-associated macrophages in type 2 diabetes. Diabetes (2007) 56(9):2356-70. doi:10.2337/db06-1650
14. Richardson SJ, Willcox A, Bone AJ, Foulis AK, Morgan NG. Islet-associated macrophages in type 2 diabetes. Diabetologia (2009) 52(8):1686-8. doi:10.1007/s00125-009-1410-z
15. Racanelli V, Rehermann B. The liver as an immunological organ. Hepatology (2006) 43(2 Suppl 1):S54-62. doi:10.1002/hep.21060
16. Nemeth E, Baird AW, O'Farrelly C. Microanatomy of the liver immune system. Semin Immunopathol (2009) 31(3):333-43. doi:10.1007/s00281-009-0173-4
17. Crispe IN. The liver as a lymphoid organ. Annu Rev Immunol (2009) 27:147-63. doi:10.1146/annurev.immunol.021908.132629
18. Robinson MW, Harmon C, O'Farrelly C. Liver immunology and its role in inflammation and homeostasis. Cell Mol Immunol (2016) 13(3):267-76. doi:10.1038/cmi.2016.3
19. Cai D, Yuan M, Frantz DF, Melendez PA, Hansen L, Lee J, et al. Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB. Nat Med (2005) 11(2):183-90. doi:10.1038/nm1166
20. Jager J, Aparicio-Vergara M, Aouadi M. Liver innate immune cells and insulin resistance: the multiple facets of Kupffer cells. J Intern Med (2016) 280(2):209-20. doi:10.1111/joim.12483
21. Jacob AI, Goldberg PK, Bloom N, Degenshein GA, Kozinn PJ. Endotoxin and bacteria in portal blood. Gastroenterology (1977) 72(6):1268-70.
22. Knolle P, Schlaak J, Uhrig A, Kempf P, Meyer zum Buschenfelde KH, Gerken G. Human Kupffer cells secrete IL-10 in response to lipopolysaccharide (LPS) challenge. J Hepatol (1995) 22(2):226-9. doi:10.1016/0168-8278(95)80433-1
23. Devisscher L, Verhelst X, Colle I, Van Vlierberghe H, Geerts A. The role of macrophages in obesity-driven chronic liver disease. J Leukoc Biol (2016) 99(5):693-8. doi:10.1189/jlb.5RU0116-016R
24. Varol C, Mildner A, Jung S. Macrophages: development and tissue specialization. Annu Rev Immunol (2015) 33:643-75. doi:10.1146/annurev-immunol-032414-112220
25. Martinez FO, Gordon S. The M1 and M2 paradigm of macrophage activation: time for reassessment. F1000Prime Rep (2014) 6:13. doi:10.12703/P6-13
26. Galvan-Pena S, O'Neill LA. Metabolic reprograming in macrophage polarization. Front Immunol (2014) 5:420. doi:10.3389/fimmu.2014.00420
27. Kang K, Reilly SM, Karabacak V, Gangl MR, Fitzgerald K, Hatano B, et al. Adipocyte-derived Th2 cytokines and myeloid PPARdelta regulate macrophage polarization and insulin sensitivity. Cell Metab (2008) 7(6):485-95. doi:10.1016/j.cmet.2008.04.002
28. Odegaard JI, Ricardo-Gonzalez RR, Red Eagle A, Vats D, Morel CR, Goforth MH, et al. Alternative M2 activation of Kupffer cells by PPARdelta ameliorates obesity-induced insulin resistance. Cell Metab (2008) 7(6):496-507. doi:10.1016/j.cmet.2008.04.003
29. Dey A, Allen J, Hankey-Giblin PA. Ontogeny and polarization of macrophages in inflammation: blood monocytes versus tissue macrophages. Front Immunol (2015) 5:683. doi:10.3389/fimmu.2014.00683
30. Widmann JJ, Cotran RS, Fahimi HD. Mononuclear phagocytes (Kupffer cells) and endothelial cells. Identification of two functional cell types in rat liver sinusoids by endogenous peroxidase activity. J Cell Biol (1972) 52(1):159-70. doi:10.1083/jcb.52.1.159
31. Vivier E, Raulet DH, Moretta A, Caligiuri MA, Zitvogel L, Lanier LL, et al. Innate or adaptive immunity? The example of natural killer cells. Science (2011) 331(6013):44-9. doi:10.1126/science.1198687
32. Yokoyama WM, Sojka DK, Peng H, Tian Z. Tissue-resident natural killer cells. Cold Spring Harb Symp Quant Biol (2013) 78:149-56. doi:10.1101/sqb.2013.78.020354
33. Hautekeete ML, Geerts A. The hepatic stellate (Ito) cell: its role in human liver disease. Virchows Arch (1997) 430(3):195-207. doi:10.1007/BF01324802
34. DeLeve LD. Liver sinusoidal endothelial cells and liver regeneration. J Clin Invest (2013) 123(5):1861-6. doi:10.1172/JCI66025
35. Austyn JM, Gordon S. F4/80, a monoclonal antibody directed specifically against the mouse macrophage. Eur J Immunol (1981) 11(10):805-15. doi:10.1002/eji.1830111013
36. Peng H, Jiang X, Chen Y, Sojka DK, Wei H, Gao X, et al. Liver-resident NK cells confer adaptive immunity in skin-contact inflammation. J Clin Invest (2013) 123(4):1444-56. doi:10.1172/JCI66381
37. Neubauer K, Knittel T, Aurisch S, Fellmer P, Ramadori G. Glial fibrillary acidic protein - a cell type specific marker for Ito cells in vivo and in vitro. J Hepatol (1996) 24(6):719-30. doi:10.1016/S0168-8278(96)80269-8
38. Gard AL, White FP, Dutton GR. Extra-neural glial fibrillary acidic protein (GFAP) immunoreactivity in perisinusoidal stellate cells of rat liver. J Neuroimmunol (1985) 8(4-6):359-75. doi:10.1016/S0165-5728(85)80073-4
39. Baratta JL, Ngo A, Lopez B, Kasabwalla N, Longmuir KJ, Robertson RT. Cellular organization of normal mouse liver: a histological, quantitative immunocytochemical, and fine structural analysis. Histochem Cell Biol (2009) 131(6):713-26. doi:10.1007/s00418-009-0577-1
40. Bouwens L, Baekeland M, De Zanger R, Wisse E. Quantitation, tissue distribution and proliferation kinetics of Kupffer cells in normal rat liver. Hepatology (1986) 6(4):718-22. doi:10.1002/hep.1840060430
41. Wisse E. Observations on the fine structure and peroxidase cytochemistry of normal rat liver Kupffer cells. J Ultrastruct Res (1974) 46(3):393-426. doi:10.1016/S0022-5320(74)90064-1
42. Wisse E. Kupffer cell reactions in rat liver under various conditions as observed in the electron microscope. J Ultrastruct Res (1974) 46(3):499-520. doi:10.1016/S0022-5320(74)90070-7
43. Laskin DL, Weinberger B, Laskin JD. Functional heterogeneity in liver and lung macrophages. J Leukoc Biol (2001) 70(2):163-70.
44. Sleyster EC, Knook DL. Relation between localization and function of rat liver Kupffer cells. Lab Invest (1982) 47(5):484-90.
45. Hickey MJ, Kubes P. Intravascular immunity: the host-pathogen encounter in blood vessels. Nat Rev Immunol (2009) 9(5):364-75. doi:10.1038/nri2532
46. Wisse E, De Zanger RB, Charels K, Van Der Smissen P, McCuskey RS. The liver sieve: considerations concerning the structure and function of endothelial fenestrae, the sinusoidal wall and the space of Disse. Hepatology (1985) 5(4):683-92. doi:10.1002/hep.1840050427
47. Bouwens L, Geerts A, Van Bossuyt H, Wisse E. Recent insights into the function of hepatic sinusoidal cells. Neth J Med (1987) 31(3-4):129-48.
48. Wake K, Decker K, Kirn A, Knook DL, McCuskey RS, Bouwens L, et al. Cell biology and kinetics of Kupffer cells in the liver. Int Rev Cytol (1989) 118:173-229. doi:10.1016/S0074-7696(08)60875-X
49. Toth CA, Thomas P. Liver endocytosis and Kupffer cells. Hepatology (1992) 16(1):255-66. doi:10.1002/hep.1840160137
50. Smedsrod B, De Bleser PJ, Braet F, Lovisetti P, Vanderkerken K, Wisse E, et al. Cell biology of liver endothelial and Kupffer cells. Gut (1994) 35(11):1509-16. doi:10.1136/gut.35.11.1509
51. Vivier E, Tomasello E, Baratin M, Walzer T, Ugolini S. Functions of natural killer cells. Nat Immunol (2008) 9(5):503-10. doi:10.1038/ni1582
52. Fasbender F, Widera A, Hengstler JG, Watzl C. Natural killer cells and liver fibrosis. Front Immunol (2016) 7:19. doi:10.3389/fimmu.2016.00019
53. Peng H, Wisse E, Tian Z. Liver natural killer cells: subsets and roles in liver immunity. Cell Mol Immunol (2016) 13(3):328-36. doi:10.1038/cmi.2015.96
54. Sato M, Suzuki S, Senoo H. Hepatic stellate cells: unique characteristics in cell biology and phenotype. Cell Struct Funct (2003) 28(2):105-12. doi:10.1247/csf.28.105
55. Li JT, Liao ZX, Ping J, Xu D, Wang H. Molecular mechanism of hepatic stellate cell activation and antifibrotic therapeutic strategies. J Gastroenterol (2008) 43(6):419-28. doi:10.1007/s00535-008-2180-y
56. Elvevold K, Smedsrod B, Martinez I. The liver sinusoidal endothelial cell: a cell type of controversial and confusing identity. Am J Physiol Gastrointest Liver Physiol (2008) 294(2):G391-400. doi:10.1152/ajpgi.00167.2007
57. van Herpen NA, Schrauwen-Hinderling VB. Lipid accumulation in non-adipose tissue and lipotoxicity. Physiol Behav (2008) 94(2):231-41. doi:10.1016/j.physbeh.2007.11.049
58. Wree A, Kahraman A, Gerken G, Canbay A. Obesity affects the liver - the link between adipocytes and hepatocytes. Digestion (2011) 83(1-2):124-33. doi:10.1159/000318741
59. Neuschwander-Tetri BA. Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: the central role of nontriglyceride fatty acid metabolites. Hepatology (2010) 52(2):774-88. doi:10.1002/hep.23719
60. Henao-Mejia J, Elinav E, Jin C, Hao L, Mehal WZ, Strowig T, et al. Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity. Nature (2012) 482(7384):179-85. doi:10.1038/nature10809
61. Johnson AM, Costanzo A, Gareau MG, Armando AM, Quehenberger O, Jameson JM, et al. High fat diet causes depletion of intestinal eosinophils associated with intestinal permeability. PLoS One (2015) 10(4):e0122195. doi:10.1371/journal.pone.0122195
62. Llorente C, Schnabl B. The gut microbiota and liver disease. Cell Mol Gastroenterol Hepatol (2015) 1(3):275-84. doi:10.1016/j.jcmgh.2015.04.003
63. Gressner AM, Bachem MG. Molecular mechanisms of liver fibrogenesis - a homage to the role of activated fat-storing cells. Digestion (1995) 56(5):335-46. doi:10.1159/000201257
64. Buzzetti E, Pinzani M, Tsochatzis EA. The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD). Metabolism (2016) 65(8):1038-48. doi:10.1016/j.metabol.2015.12.012
65. Gruben N, Shiri-Sverdlov R, Koonen DP, Hofker MH. Nonalcoholic fatty liver disease: a main driver of insulin resistance or a dangerous liaison? Biochim Biophys Acta (2014) 1842(11):2329-43. doi:10.1016/j.bbadis.2014.08.004
66. Dixon LJ, Barnes M, Tang H, Pritchard MT, Nagy LE. Kupffer cells in the liver. Compr Physiol (2013) 3(2):785-97. doi:10.1002/cphy.c120026
67. Kolios G, Valatas V, Kouroumalis E. Role of Kupffer cells in the pathogenesis of liver disease. World J Gastroenterol (2006) 12(46):7413-20. doi:10.3748/wjg.v12.i46.7413
68. Goss JA, Mangino MJ, Callery MP, Flye MW. Prostaglandin E2 downregulates Kupffer cell production of IL-1 and IL-6 during hepatic regeneration. Am J Physiol (1993) 264(4 Pt 1):G601-8.
69. Roland CR, Goss JA, Mangino MJ, Hafenrichter D, Flye MW. Autoregulation by eicosanoids of human Kupffer cell secretory products. A study of interleukin-1, interleukin-6, tumor necrosis factor-alpha, transforming growth factor-beta, and nitric oxide. Ann Surg (1994) 219(4):389-99. doi:10.1097/00000658-199404000-00010
70. Henkel J, Neuschafer-Rube F, Pathe-Neuschafer-Rube A, Puschel GP. Aggravation by prostaglandin E2 of interleukin-6-dependent insulin resistance in hepatocytes. Hepatology (2009) 50(3):781-90. doi:10.1002/hep.23064
71. Henkel J, Gartner D, Dorn C, Hellerbrand C, Schanze N, Elz SR, et al. Oncostatin M produced in Kupffer cells in response to PGE2: possible contributor to hepatic insulin resistance and steatosis. Lab Invest (2011) 91(7):1107-17. doi:10.1038/labinvest.2011.47
72. Klueh U, Czajkowski C, Ludzinska I, Qiao Y, Frailey J, Kreutzer DL. Impact of CCL2 and CCR2 chemokine/receptor deficiencies on macrophage recruitment and continuous glucose monitoring in vivo. Biosens Bioelectron (2016) 86:262-9. doi:10.1016/j.bios.2016.06.026
73. Weisberg SP, Hunter D, Huber R, Lemieux J, Slaymaker S, Vaddi K, et al. CCR2 modulates inflammatory and metabolic effects of high-fat feeding. J Clin Invest (2006) 116(1):115-24. doi:10.1172/JCI24335C1
74. Tosello-Trampont AC, Landes SG, Nguyen V, Novobrantseva TI, Hahn YS. Kuppfer cells trigger nonalcoholic steatohepatitis development in diet-induced mouse model through tumor necrosis factor-alpha production. J Biol Chem (2012) 287(48):40161-72. doi:10.1074/jbc.M112.417014
75. Sun K, Tordjman J, Clement K, Scherer PE. Fibrosis and adipose tissue dysfunction. Cell Metab (2013) 18(4):470-7. doi:10.1016/j.cmet.2013.06.016
76. Pradere JP, Kluwe J, De Minicis S, Jiao JJ, Gwak GY, Dapito DH, et al. Hepatic macrophages but not dendritic cells contribute to liver fibrosis by promoting the survival of activated hepatic stellate cells in mice. Hepatology (2013) 58(4):1461-73. doi:10.1002/hep.26429
77. Karlmark KR, Weiskirchen R, Zimmermann HW, Gassler N, Ginhoux F, Weber C, et al. Hepatic recruitment of the inflammatory Gr1+ monocyte subset upon liver injury promotes hepatic fibrosis. Hepatology (2009) 50(1):261-74. doi:10.1002/hep.22950
78. Baeck C, Wehr A, Karlmark KR, Heymann F, Vucur M, Gassler N, et al. Pharmacological inhibition of the chemokine CCL2 (MCP-1) diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injury. Gut (2012) 61(3):416-26. doi:10.1136/gutjnl-2011-300304
79. Ehling J, Bartneck M, Wei X, Gremse F, Fech V, Mockel D, et al. CCL2-dependent infiltrating macrophages promote angiogenesis in progressive liver fibrosis. Gut (2014) 63(12):1960-71. doi:10.1136/gutjnl-2013-306294
80. Baeck C, Wei X, Bartneck M, Fech V, Heymann F, Gassler N, et al. Pharmacological inhibition of the chemokine C-C motif chemokine ligand 2 (monocyte chemoattractant protein 1) accelerates liver fibrosis regression by suppressing Ly-6C(+) macrophage infiltration in mice. Hepatology (2014) 59(3):1060-72. doi:10.1002/hep.26783
81. Zimmermann HW, Tacke F. In search of the magic bullet: can liver inflammation and fibrosis be reversed with medications? Expert Rev Gastroenterol Hepatol (2015) 9(9):1139-41. doi:10.1586/17474124.2015.1063417
82. Lackey DE, Olefsky JM. Regulation of metabolism by the innate immune system. Nat Rev Endocrinol (2016) 12(1):15-28. doi:10.1038/nrendo.2015.189
83. Movita D, Kreefft K, Biesta P, van Oudenaren A, Leenen PJ, Janssen HL, et al. Kupffer cells express a unique combination of phenotypic and functional characteristics compared with splenic and peritoneal macrophages. J Leukoc Biol (2012) 92(4):723-33. doi:10.1189/jlb.1111566
84. Lloyd CM, Phillips AR, Cooper GJ, Dunbar PR. Three-colour fluorescence immunohistochemistry reveals the diversity of cells staining for macrophage markers in murine spleen and liver. J Immunol Methods (2008) 334(1-2):70-81. doi:10.1016/j.jim.2008.02.005
85. Klein I, Cornejo JC, Polakos NK, John B, Wuensch SA, Topham DJ, et al. Kupffer cell heterogeneity: functional properties of bone marrow derived and sessile hepatic macrophages. Blood (2007) 110(12):4077-85. doi:10.1182/blood-2007-02-073841
86. Kim S, Sohn I, Ahn JI, Lee KH, Lee YS, Lee YS. Hepatic gene expression profiles in a long-term high-fat diet-induced obesity mouse model. Gene (2004) 340(1):99-109. doi:10.1016/j.gene.2004.06.015
87. Kelder T, Eijssen L, Kleemann R, van Erk M, Kooistra T, Evelo C. Exploring pathway interactions in insulin resistant mouse liver. BMC Syst Biol (2011) 5:127. doi:10.1186/1752-0509-5-127
88. Zhang F, Xu X, Zhang Y, Zhou B, He Z, Zhai Q. Gene expression profile analysis of type 2 diabetic mouse liver. PLoS One (2013) 8(3):e57766. doi:10.1371/journal.pone.0057766
89. Connor SC, Hansen MK, Corner A, Smith RF, Ryan TE. Integration of metabolomics and transcriptomics data to aid biomarker discovery in type 2 diabetes. Mol Biosyst (2010) 6(5):909-21. doi:10.1039/b914182k
90. Wruck W, Kashofer K, Rehman S, Daskalaki A, Berg D, Gralka E, et al. Multi-omic profiles of human non-alcoholic fatty liver disease tissue highlight heterogenic phenotypes. Sci Data (2015) 2:150068. doi:10.1038/sdata.2015.68
91. Elam MB, Cowan GS Jr, Rooney RJ, Hiler ML, Yellaturu CR, Deng X, et al. Hepatic gene expression in morbidly obese women: implications for disease susceptibility. Obesity (Silver Spring) (2009) 17(8):1563-73. doi:10.1038/oby.2009.49
92. Suh YH, Kim Y, Bang JH, Choi KS, Lee JW, Kim WH, et al. Analysis of gene expression profiles in insulin-sensitive tissues from pre-diabetic and diabetic Zucker diabetic fatty rats. J Mol Endocrinol (2005) 34(2):299-315. doi:10.1677/jme.1.01679
93. Zhou H, Saito S, Piao G, Liu ZP, Wang J, Horimoto K, et al. Network screening of Goto-Kakizaki rat liver microarray data during diabetic progression. BMC Syst Biol (2011) 5(Suppl 1):S16. doi:10.1186/1752-0509-5-S1-S16
94. Ahrens M, Ammerpohl O, von Schonfels W, Kolarova J, Bens S, Itzel T, et al. DNA methylation analysis in nonalcoholic fatty liver disease suggests distinct disease-specific and remodeling signatures after bariatric surgery. Cell Metab (2013) 18(2):296-302. doi:10.1016/j.cmet.2013.07.004
95. Younossi ZM, Gorreta F, Ong JP, Schlauch K, Del Giacco L, Elariny H, et al. Hepatic gene expression in patients with obesity-related non-alcoholic steatohepatitis. Liver Int (2005) 25(4):760-71. doi:10.1111/j.1478-3231.2005.01117.x
96. Reid DT, Reyes JL, McDonald BA, Vo T, Reimer RA, Eksteen B. Kupffer cells undergo fundamental changes during the development of experimental NASH and are critical in initiating liver damage and inflammation. PLoS One (2016) 11(7):e0159524. doi:10.1371/journal.pone.0159524